Literature DB >> 12103434

Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides.

Ben Berkhout1, Jeroen L B van Wamel, Leonie Beljaars, Dirk K F Meijer, Servaas Visser, René Floris.   

Abstract

In a search for natural proteins with anti-HIV activity, we screened a large set of purified proteins from bovine milk and peptide fragments thereof. Because several charged proteins and peptides are known to inhibit the process of virus entry, we selected proteins with an unusual charge composition or hydrophobicity profile. In contrast with some chemically modified (strongly negative) milk proteins, unmodified alpha(s2)-, beta- and kappa-casein, as well as several negatively and positively charged fragments thereof, did not show significant inhibition of virus replication. In fact, HIV-1 replication was elevated in the presence of beta-casein or amphiphilic fragments thereof. Bovine lactoferrin (bLF), a milk protein of 80 kDa, showed considerable inhibitory activity against HIV-1 with an IC50 of 0.4 microM. Modest inhibition was obtained with lactoferricin, a highly positively charged loop domain of bLF, indicating that other domains within the native bLF protein may also be required for inhibition. bLF blocked HIV-1 variants that use either the CXCR4 or the CCR5 coreceptor. In order to obtain further insight into the mechanism of action of this antiviral protein, we selected a bLF-resistant HIV-1 variant. The bLF-resistance phenotype is mediated by the viral envelope protein, which contains two interesting mutations that have previously been associated with an altered virus-host interaction and a modified receptor-coreceptor interaction. These results demonstrate that bLF targets the HIV-1 entry process. Copyright 2002 ElsevierScience BV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103434     DOI: 10.1016/s0166-3542(02)00069-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  27 in total

1.  High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.

Authors:  Andrew B Wilks; James R Perry; Elizabeth P Ehlinger; Roland C Zahn; Robert White; Marie-Claire Gauduin; Angela Carville; Michael S Seaman; Joern E Schmitz; Sallie R Permar
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

2.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

3.  Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interaction.

Authors:  Fedde Groot; Teunis B H Geijtenbeek; Rogier W Sanders; Christopher E Baldwin; Marta Sanchez-Hernandez; René Floris; Yvette van Kooyk; Esther C de Jong; Ben Berkhout
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.

Authors:  Marloes A Naarding; Irene S Ludwig; Fedde Groot; Ben Berkhout; Teunis B H Geijtenbeek; Georgios Pollakis; William A Paxton
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

5.  Human Papillomavirus (HPV) Entry Inhibitors.

Authors:  Yun Zhu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 6.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

7.  Lack of B cell dysfunction is associated with functional, gp120-dominant antibody responses in breast milk of simian immunodeficiency virus-infected African green monkeys.

Authors:  Joshua D Amos; Andrew B Wilks; Genevieve G Fouda; Shannon D Smith; Lisa Colvin; Tatenda Mahlokozera; Carrie Ho; Krista Beck; R Glenn Overman; C Todd DeMarco; Terry L Hodge; Celia C LaBranche; David C Montefiori; Thomas N Denny; Hua-Xin Liao; Georgia D Tomaras; M Anthony Moody; Sallie R Permar
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

8.  Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk.

Authors:  Genevieve G Fouda; Frederick H Jaeger; Joshua D Amos; Carrie Ho; Erika L Kunz; Kara Anasti; Lisa W Stamper; Brooke E Liebl; Kimberly H Barbas; Tomoo Ohashi; Martin Arthur Moseley; Hua-Xin Liao; Harold P Erickson; S Munir Alam; Sallie R Permar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

9.  Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide.

Authors:  Laetitia Carthagena; Pierre Becquart; Hakim Hocini; Michel D Kazatchkine; Hicham Bouhlal; Laurent Belec
Journal:  Open Virol J       Date:  2011-04-15

Review 10.  The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity.

Authors:  Iwona Bukowska-Ośko; Marta Popiel; Paweł Kowalczyk
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.